◆英語タイトル：Immucor, Inc. - Strategic SWOT Analysis Review
◆商品コード：DATA8012806
◆発行会社（調査会社）：
GlobalData
◆発行日：2017年11月29日
◆ページ数：29
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
Immucor, Inc. – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
Highlights
Immucor, Inc. (Immucor) is an in-vitro diagnostics company, which specializes in the area of pre-transfusion diagnostics. It carries out the development, production and sale of a comprehensive line of reagents and automated systems. The company’s products are used in performing the tests to detect and identify certain properties of the cell and serum components of human blood before the process of blood transfusion. Its major customers include hospitals, clinical laboratories and blood banks. Immucor offers its solutions to blood banks, transfusion laboratories and small- and medium-sized hospitals. The company has operations in Germany, Italy, Portugal, Canada, Spain, Belgium, France, India, Japan, the UK and the US; and it has manufacturing facilities in US and Canada. Immucor is headquartered in Norcross, Georgia, the US.
Immucor, Inc. Key Recent Developments
Jul 26,2017: Immucor and Mohawk Medbuy Corporation Sign 10 Year Automation Agreement for CoLabs
Feb 17,2017: Immucor Announces the Launch of Pak Lx RUO in the United States
Aug 29,2016: Brookfield Immucor expansion means 64 new high-skilled jobs
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Immucor, Inc. – Key Facts 5
Immucor, Inc. – Key Employees 6
Immucor, Inc. – Key Employee Biographies 7
Immucor, Inc. – Major Products and Services 8
Immucor, Inc. – History 10
Immucor, Inc. – Company Statement 12
Immucor, Inc. – Locations And Subsidiaries 13
Head Office 13
Other Locations & Subsidiaries 13
Section 2 – Company Analysis 16
Immucor, Inc. – Business Description 16
Immucor, Inc. – Corporate Strategy 17
Immucor, Inc. – SWOT Analysis 18
SWOT Analysis – Overview 18
Immucor, Inc. – Strengths 18
Immucor, Inc. – Weaknesses 19
Immucor, Inc. – Opportunities 20
Immucor, Inc. – Threats 21
Immucor, Inc. – Key Competitors 22
Section 3 – Company’s Lifesciences Financial Deals and Alliances 23
Immucor, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 23
Immucor, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 24
Immucor, Inc., Recent Deals Summary 25
Section 4 – Company’s Recent Developments 26
Feb 17, 2017: Immucor Announces the Launch of Pak Lx RUO in the United States 26
Mar 21, 2016: Immucor’s ImmuLINK Software Suite v1.7 Receives FDA Clearance to Interface with PreciseType HEA 27
Feb 03, 2016: Immucor and Sirona Genomics Announce CE Mark for MIA FORA NGS HLA Typing Solution 28
Section 5 – Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List of Tables
Immucor, Inc., Key Facts 5
Immucor, Inc., Key Employees 6
Immucor, Inc., Key Employee Biographies 7
Immucor, Inc., Major Products and Services 8
Immucor, Inc., History 10
Immucor, Inc., Other Locations 13
Immucor, Inc., Subsidiaries 14
Immucor, Inc., Key Competitors 22
Immucor, Inc., Medical Equipment, Deals By Year, 2011 to YTD 2017 23
Immucor, Inc., Medical Equipment, Deals By Type, 2011 to YTD 2017 24
Immucor, Inc., Recent Deals Summary 25
